Stock·NYSE·Consumer Defensive
Target Corp. (TGT)
- Market cap
- $71.16B
- P/E
- 15.79
- Dividend yield
- 2.92%
- Street target
- $164.00median of 38 analysts
- 52-week range
- $83.44 $170.75
The short version
Where TGT stands today, in four lines, and what CleaRank Financial AI makes of it.
TGT at a glance
Target Corp. (TGT): Hold, 55/100 on CleaRank's AI score.
- Trend Mixed: the price is above its 200-day but below its 50-day moving average ($131.35 and $157.34).
- Earnings TGT beat estimates in 5 of its last 7 quarters, yet fell the next day after 4 of those beats.
- Insiders Insiders sold $30.5M and made no open-market purchases over the last 18 months.
- Valuation P/E of 15.8 against 24.2 for the Consumer Defensive sector: a discount to peers (-35%).
Figures as of October 16, 2026.
CleaRank Financial AI
The stock is trading above its 200-day simple moving average of $131.35, suggesting a longer-term uptrend remains intact.
Wall Street analysts collectively hold a 'Hold' rating with a median price target of $164.00, implying a modest 4.7% upside from current levels. Fundamentally, Target Corp. exhibits a profit margin of 4.08% and a return on equity of 26.41%, which is strong relative to the Consumer Defensive sector's median ROE of 19.7%. However, its price-to-sales ratio of 0.66 is below the sector median of 2.2, suggesting potential value. The company's debt-to-equity ratio stands at 1.08, aligning with the sector average.
Only on CleaRank
Figures we compute ourselves from TGT's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
3/4Price above its 50-day average ›
The price of $156.63 is 0.4% below the 50-day simple moving average of $157.34.Price above its 200-day average ›
The price is 19.2% above the 200-day simple moving average of $131.35.50-day average above the 200-day ›
The 50-day average ($157.34) is 19.8% above the 200-day average ($131.35), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 84% of its 52-week range, between $83.44 and $170.75.
TGT share price
Pick a period: each tab shows how far TGT has moved over it, to the last close.
Today's trading
Where TGT sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
5/5P/E below the sector median ›
The trailing P/E of 15.79 is 34.8% below the Consumer Defensive median of 24.2.P/S below the sector median ›
The price-to-sales ratio of 0.66 is 70.0% below the sector median of 2.2.Profitable over the last 12 months ›
Net income over the last 12 months was $4.4B on revenue of $107.7B, a net margin of 4.1%.Beat estimates in most recent reports ›
TGT beat the EPS estimate in 5 of its last 7 reports.Pays a dividend ›
The trailing dividend yield is 2.92%, or $4.58 a share a year.
Key statistics
The headline figures for TGT.
As of October 16, 2026, TGT trades at $156.63, with a market value of $71.16B, a P/E ratio of 15.79 and a dividend yield of 2.92%.
What the numbers say
CleaRank Financial AI's reading of TGT's valuation, growth and risks.
Target Corp. (TGT) presents a mixed fundamental picture with a price-to-earnings ratio of 15.79, which is below the Consumer Defensive sector median of 24.2.
Its price-to-sales ratio of 0.66 is also significantly lower than the sector average of 2.2, indicating that the market is valuing its revenue less richly than its peers. The company's return on equity stands at a strong 26.41%, well above the sector median of 19.7%, demonstrating strong profitability on shareholder capital. While the company's profit margin is 4.08% and operating margin is 6.04%, its debt-to-equity ratio of 1.08 is in line with the sector average. The company's revenue growth is reported at 5.3%, matching the sector average, but forward-looking revenue growth estimates for the next year are projected at 3.00%, indicating a potential slowdown.
TGT against the Consumer Defensive sector
How TGT compares with the median Consumer Defensive stock CleaRank tracks.
Price to earnings vs sector: TGT trades at a notable discount to sector peers (-35%), which may indicate undervaluation or specific company headwinds.
Return vs VDC: Since May 5, 2025, TGT has gained 66.6% against a gain of 6.5% for VDC.
Performance against VDC
TGT and the Consumer Defensive sector fund over the same days.
Revenue and earnings
How much TGT sells, and how much of it becomes profit.
Revenue growth: Revenue fell 1.7% in FY2026 to $105B, from $107B a year earlier.
Profit margin: The net margin was 3.5% in FY2026, down from 3.8% the year before.
Profitable: TGT earned $3.7B in FY2026.
Earnings reality check
Did TGT beat what analysts expected, and how did the stock react?
Earnings record: TGT beat the analyst estimate in 5 of the last 7 quarters.
Market reaction: The stock fell in the first session after 4 of those 5 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Aug 19, 2026after close | $2.34 | $4.11 | +75.64% | -0.47% | +3.17% |
| May 20, 2026after close | $1.46 | $1.71 | +17.12% | +3.12% | +5.17% |
| Nov 19, 2025after close | $1.71 | $1.78 | +4.09% | -2.79% | +4.32% |
| Aug 20, 2025after close | $2.03 | $2.05 | +0.99% | -1.65% | -0.74% |
| May 21, 2025after close | $1.65 | $1.30 | -21.21% | +2.20% | +2.00% |
| Mar 4, 2025after close | $2.25 | $2.41 | +7.11% | -0.50% | -3.74% |
| Nov 20, 2024after close | $2.30 | $1.85 | -19.57% | -0.11% | +6.88% |
As of October 16, 2026, TGT has beaten the analyst EPS estimate in 5 of its last 7 reported quarters and fell in the first trading session after 4 of those beats; its latest report, on August 19, 2026, came in 75.64% above the estimate and the stock moved -0.47% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
2/3RSI not overbought or oversold ›
The 14-day RSI is 52.3, in neutral territory.RSI above 50 ›
An RSI of 52.3 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of TGT
The score, the reasoning behind it, and what could move the price next.
The 14-day RSI is at 52.29, indicating neutral momentum.
The MACD is currently at -0.70, suggesting a slight bearish divergence. Volume on the latest trading day was 3,542,700, which is approximately 10.9% below the average daily volume of 3,977,660. Key support can be observed around the $155.40 level (20-day EMA), while resistance lies at the 50-day SMA of $157.34. The current technical setup suggests a consolidation phase with limited immediate directional conviction.
Moderate Insider Selling Signal ›
Insiders have sold approximately $30.5 million worth of stock with no reported purchases, indicating a net seller position across recent filings, which warrants monitoring.
Source: Insider Trading DataAnalyst Consensus Remains 'Hold' ›
Despite recent strong earnings, the majority of Wall Street analysts maintain a 'Hold' rating, reflecting a balanced view on the stock's near-term prospects.
Source: Wall Street Analysts
Trading Below 50-Day SMA Resistance ›
The stock is currently trading below its 50-day simple moving average of $157.34, which is acting as a near-term resistance level.
Source: Technical Analysis
- Target Corp.'s (TGT) strong return on equity (26.41%) and below-sector average P/S ratio (0.66) suggest solid operational efficiency and potential value, which could support the stock if broader market sentiment improves.
Technical indicators
Momentum and trend for TGT, from its daily closes.
As of October 16, 2026, with TGT at $156.63, its 14-day RSI is 52.3 (neutral territory), its 50-day simple moving average is $157.34 and its 200-day is $131.35.
Calculated by CleaRank on daily closes as of October 16, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What TGT moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 16, 2026, TGT's 1-year correlation of daily returns is +0.32 with S&P 500 (SPY), +0.23 with Nasdaq 100 (QQQ), +0.13 with Bitcoin (BTC) and -0.04 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
13 of 38 analysts rate it a buy or strong buy, 21 a hold and 4 a sell.Median target above the price ›
The median 12-month target of $164.00 is 4.7% above the price.More buy ratings than three months ago ›
13 of 38 rate it a buy now, against 12 of 38 three months ago.
TGT Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Sep 30, 2026 | HSBC | Upgrade | Buy |
| Aug 20, 2026 | Telsey Advisory Group | Maintains | Outperform |
| Aug 20, 2026 | Citigroup | Maintains | Neutral |
| Aug 20, 2026 | Goldman Sachs | Maintains | Neutral |
| Aug 20, 2026 | BMO Capital | Maintains | Market Perform |
| Aug 20, 2026 | Truist Securities | Maintains | Hold |
As of October 16, 2026, 38 Wall Street analysts cover TGT: 13 rate it a buy or strong buy, 21 a hold and 4 a sell or strong sell. Their 12-month price targets range from $128.00 to $200.00, with a median of $164.00, 4.7% above the price of $156.63.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
TGT trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from TGT's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much TGT tends to move, against the market and on its own.
The long record
TGT's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
2/4Average daily move under 2% ›
The price has moved 1.49% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 63.5%, from November 2021 to April 2025; the price is still 31.6% below that peak.Most 1-year holds ended higher ›
64% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $31,372, against $42,525 in the S&P 500 (SPY).
TGT Drawdowns & Recovery
As of October 16, 2026, TGT's worst peak-to-trough fall over the last 10 years with dividends reinvested was -63.5% (November 2021 to April 2025); it is still 31.6% below that peak, and 64% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into TGT in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: TGT trailed the S&P 500 over this period: $31,372 against $42,525.
A $10,000 investment in TGT in October 2016 would be worth about $31,372 today with dividends reinvested, compared with about $42,525 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to TGT, and which have not.
Strongest month, August: an average of +5.49%, up in 5 of 10 years.
Weakest month, May: an average of -3.46%, up in 5 of 10 years.
This month, October: has averaged +2.14%, up in 5 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, TGT's strongest calendar month has been August (average +5.49%, up in 5 of 10 years) and its weakest May (average -3.46%, up in 5 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in TGT, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in TGT today could grow to about $20,271 by 2036 in the base case, with a 90th-percentile outcome near $80,296 and a 10th-percentile outcome around $5,117. The simulation models price only; at today's 2.92% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
TGT Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $208 for TGT by 2030 in the base case, from $157 today (1.3x over 4 years). The 10th-percentile path ends near $87.00. These are outcomes of a Monte Carlo simulation run on TGT's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $109 | $168 | $260 | |
| 2028 | $97.48 | $180 | $334 | |
| 2029 | $91.10 | $194 | $412 | |
| 2030 | $87.00 | $208 | $496 | |
| 2031 | $84.25 | $223 | $590 |
Method: a lognormal simulation of TGT's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
TGT insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: No insider bought TGT shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 16, 2026, TGT insiders reported 10 open-market sales worth $30.5M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Aug 25, 2026 | Brian C Cornell
Officer and Director
|
Sell | 50.0K | $8.2M |
| Aug 24, 2026 | Melissa K Kremer
Officer
|
Sell | 15.5K | $2.6M |
| Aug 21, 2026 | Matthew A Liegel
Officer
|
Sell | 926 | $151.4K |
| Aug 3, 2026 | Joseph Michael Depinto
Director
|
Grant | 1.0K | - |
| Jun 30, 2026 | Grant B Mcgee
Officer
|
Grant | 19.4K | - |
| Jun 29, 2026 | Lisa R Roath
Officer
|
Sell | 7.0K | $966.5K |
| May 29, 2026 | Cara A Sylvester
Officer
|
Sell | 10.0K | $1.3M |
| May 27, 2026 | Brian C Cornell
Officer and Director
|
Sell | 50.0K | $6.5M |
| Apr 7, 2026 | Brian C Cornell
Officer and Director
|
Grant | 50.8K | - |
| Apr 7, 2026 | Michael J. Fiddelke
Officer
|
Grant | 11.3K | - |
| Apr 7, 2026 | Melissa K Kremer
Officer
|
Grant | 7.3K | - |
| Apr 7, 2026 | Matthew A Liegel
Officer
|
Grant | 1.3K | - |
| Apr 7, 2026 | Lisa R Roath
Officer
|
Grant | 2.4K | - |
| Apr 7, 2026 | Cara A Sylvester
Officer
|
Grant | 5.8K | - |
| Apr 7, 2026 | Pratabkumar Vemana
Officer
|
Grant | 3.6K | - |
| Apr 1, 2026 | Stephen B. Bratspies
Director
|
Grant | 1.8K | - |
| Mar 17, 2026 | Matthew A Liegel
Officer
|
Sell | 2.1K | $240.6K |
| Mar 11, 2026 | David P Abney
Director
|
Grant | 1.7K | - |
| Mar 11, 2026 | Douglas M Baker Jr
Director
|
Grant | 1.7K | - |
| Mar 11, 2026 | George S Barrett
Director
|
Grant | 2.9K | - |
| Mar 11, 2026 | Gail A Koziara Boudreaux
Director
|
Grant | 2.7K | - |
| Mar 11, 2026 | Brian C Cornell
Officer and Director
|
Grant | 50.3K | - |
| Mar 11, 2026 | Robert L Edwards
Director
|
Grant | 1.7K | - |
| Mar 11, 2026 | Michael J. Fiddelke
Officer
|
Grant | 30.4K | - |
| Mar 11, 2026 | John R Hoke III
Director
|
Grant | 2.0K | - |
| Mar 11, 2026 | Donald R Knauss
Director
|
Grant | 1.7K | - |
| Mar 11, 2026 | Melissa K Kremer
Officer
|
Grant | 24.6K | - |
| Mar 11, 2026 | Christine A Leahy
Director
|
Grant | 3.1K | - |
| Mar 11, 2026 | James Lee
Officer
|
Grant | 35.9K | - |
| Mar 11, 2026 | Matthew A Liegel
Officer
|
Grant | 3.7K | - |
| Mar 11, 2026 | Monica C. Lozano
Director
|
Grant | 1.7K | - |
| Mar 11, 2026 | Derica W Rice
Director
|
Grant | 2.7K | - |
| Mar 11, 2026 | Lisa R Roath
Officer
|
Grant | 24.9K | - |
| Mar 11, 2026 | Dmitri L Stockton
Director
|
Grant | 2.9K | - |
| Mar 11, 2026 | Cara A Sylvester
Officer
|
Grant | 25.6K | - |
| Mar 11, 2026 | Pratabkumar Vemana
Officer
|
Grant | 28.2K | - |
| Mar 11, 2026 | Grace Puma Whiteford
Director
|
Grant | 1.7K | - |
| Mar 10, 2026 | Brian C Cornell
Officer and Director
|
Sell | 50.0K | $6.1M |
| Jun 10, 2025 | Matthew A Liegel
Officer
|
Sell | 2.0K | $206.2K |
| May 28, 2025 | Brian C Cornell
Officer and Director
|
Sell | 45.0K | $4.3M |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 16, 2026.